{"id":340098,"date":"2025-08-20T10:19:58","date_gmt":"2025-08-20T10:19:58","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-intellia-therapeutics\/"},"modified":"2025-08-20T10:19:58","modified_gmt":"2025-08-20T10:19:58","slug":"how-to-buy-intellia-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-340098","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Intellia Therapeutics, Inc. (NTLA) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Intellia Therapeutics, Inc. (NTLA)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Intellia Therapeutics, Inc. (NTLA) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Intellia Therapeutics, Inc. (NTLA)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Intellia Therapeutics (NTLA) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, d\u1ef1 b\u00e1o n\u0103m 2025 v\u00e0 h\u01b0\u1edbng d\u1eabn mua t\u1eebng b\u01b0\u1edbc cho c\u01a1 h\u1ed9i ch\u1ec9nh s\u1eeda gen.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Intellia Therapeutics (NTLA) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, d\u1ef1 b\u00e1o n\u0103m 2025 v\u00e0 h\u01b0\u1edbng d\u1eabn mua t\u1eebng b\u01b0\u1edbc cho c\u01a1 h\u1ed9i ch\u1ec9nh s\u1eeda gen."},"intro":"H\u00e3y t\u01b0\u1edfng t\u01b0\u1ee3ng s\u1edf h\u1eefu m\u1ed9t ph\u1ea7n c\u1ee7a t\u01b0\u01a1ng lai y h\u1ecdc. Intellia Therapeutics \u0111\u1ee9ng \u1edf tuy\u1ebfn \u0111\u1ea7u c\u1ee7a cu\u1ed9c c\u00e1ch m\u1ea1ng ch\u1ec9nh s\u1eeda gen, s\u1eed d\u1ee5ng c\u00f4ng ngh\u1ec7 CRISPR \u0111\u1ec3 c\u00f3 th\u1ec3 ch\u1eefa kh\u1ecfi c\u00e1c b\u1ec7nh di truy\u1ec1n. \u0110\u00e2y kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc th\u00f4ng th\u01b0\u1eddng \u2014 m\u00e0 l\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 v\u00e0o c\u00f4ng ngh\u1ec7 c\u00f3 th\u1ec3 thay \u0111\u1ed5i ng\u00e0nh ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe m\u00e3i m\u00e3i. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 c\u00e1ch b\u1ea1n c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh m\u1ed9t ph\u1ea7n c\u1ee7a h\u00e0nh tr\u00ecnh \u0111\u1ed9t ph\u00e1 n\u00e0y.","intro_source":{"label":"Intro","type":"text","formatted_value":"H\u00e3y t\u01b0\u1edfng t\u01b0\u1ee3ng s\u1edf h\u1eefu m\u1ed9t ph\u1ea7n c\u1ee7a t\u01b0\u01a1ng lai y h\u1ecdc. Intellia Therapeutics \u0111\u1ee9ng \u1edf tuy\u1ebfn \u0111\u1ea7u c\u1ee7a cu\u1ed9c c\u00e1ch m\u1ea1ng ch\u1ec9nh s\u1eeda gen, s\u1eed d\u1ee5ng c\u00f4ng ngh\u1ec7 CRISPR \u0111\u1ec3 c\u00f3 th\u1ec3 ch\u1eefa kh\u1ecfi c\u00e1c b\u1ec7nh di truy\u1ec1n. \u0110\u00e2y kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc th\u00f4ng th\u01b0\u1eddng \u2014 m\u00e0 l\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 v\u00e0o c\u00f4ng ngh\u1ec7 c\u00f3 th\u1ec3 thay \u0111\u1ed5i ng\u00e0nh ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe m\u00e3i m\u00e3i. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 c\u00e1ch b\u1ea1n c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh m\u1ed9t ph\u1ea7n c\u1ee7a h\u00e0nh tr\u00ecnh \u0111\u1ed9t ph\u00e1 n\u00e0y."},"body_html":"<h2>\ud83d\udcc8 V\u1ecb Tr\u00ed Th\u1ecb Tr\u01b0\u1eddng Hi\u1ec7n T\u1ea1i v\u00e0 Chi\u1ebfn L\u01b0\u1ee3c Giao D\u1ecbch<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 20 th\u00e1ng 8 n\u0103m 2025, Intellia Therapeutics (NTLA) \u0111ang giao d\u1ecbch \u1edf m\u1ee9c <strong>10,21 USD<\/strong>, \u0111\u01b0\u1ee3c nhi\u1ec1u nh\u00e0 ph\u00e2n t\u00edch xem l\u00e0 c\u01a1 h\u1ed9i mua ti\u1ec1m n\u0103ng trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc bi\u1ebfn \u0111\u1ed9ng. C\u1ed5 phi\u1ebfu \u0111\u00e3 ch\u1ecbu \u00e1p l\u1ef1c \u0111\u00e1ng k\u1ec3 g\u1ea7n \u0111\u00e2y, nh\u01b0ng \u0111i\u1ec1u n\u00e0y c\u00f3 th\u1ec3 l\u00e0 \u0111i\u1ec3m v\u00e0o h\u1ea5p d\u1eabn cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n.<\/p> <p><strong>\u0110\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: ng\u00e0y 6 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y quan tr\u1ecdng ti\u1ebfp theo khi Intellia c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c b\u00e1o c\u00e1o n\u00e0y th\u01b0\u1eddng l\u00e0m c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh. Nh\u00ecn l\u1ea1i b\u00e1o c\u00e1o qu\u00fd 2 ng\u00e0y 7 th\u00e1ng 8 n\u0103m 2025, c\u00f4ng ty \u0111\u00e3 b\u00e1o c\u00e1o k\u1ebft qu\u1ea3 \u1ea5n t\u01b0\u1ee3ng v\u1edbi doanh thu h\u1ee3p t\u00e1c t\u0103ng <strong>106%<\/strong> l\u00ean 14,2 tri\u1ec7u USD, v\u01b0\u1ee3t k\u1ef3 v\u1ecdng c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch<a href=\"https:\/\/www.aol.com\/finance\/intellia-ntla-q2-revenue-jumps-152350711.html\">AOL Finance<\/a>.<\/p> <h3>Ph\u00e2n T\u00edch T\u00e1c \u0110\u1ed9ng L\u1ecbch S\u1eed Thu Nh\u1eadp<\/h3> <table> <thead> <tr><th>Ng\u00e0y<\/th><th>S\u1ef1 ki\u1ec7n<\/th><th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th><th>Thay \u0110\u1ed5i Sau Tin<\/th><th>Th\u1eddi Gian<\/th><\/tr> <\/thead> <tbody> <tr><td>7 Th\u00e1ng 8, 2025<\/td><td>B\u00e1o c\u00e1o Qu\u00fd 2<\/td><td>11,37 USD<\/td><td>+0,9% (1 ng\u00e0y)<\/td><td>\u1ed4n \u0111\u1ecbnh nhanh<\/td><\/tr> <tr><td>8 Th\u00e1ng 5, 2025<\/td><td>K\u1ebft qu\u1ea3 Qu\u00fd 1<\/td><td>12,50 USD<\/td><td>-8,4%<\/td><td>S\u1ee5t gi\u1ea3m k\u00e9o d\u00e0i m\u1ed9t tu\u1ea7n<\/td><\/tr> <tr><td>6 Th\u00e1ng 2, 2025<\/td><td>B\u00e1o c\u00e1o H\u00e0ng n\u0103m<\/td><td>14,20 USD<\/td><td>+3,5%<\/td><td>T\u0103ng gi\u00e1 3 ng\u00e0y<\/td><\/tr> <tr><td>7 Th\u00e1ng 11, 2024<\/td><td>Tin \u0110\u1ed1i T\u00e1c<\/td><td>15,80 USD<\/td><td>+6,2%<\/td><td>T\u0103ng tr\u01b0\u1edfng b\u1ec1n v\u1eefng<\/td><\/tr> <tr><td>8 Th\u00e1ng 8, 2024<\/td><td>Qu\u00fd 2 N\u0103m 2024<\/td><td>16,40 USD<\/td><td>-4,8%<\/td><td>Ph\u1ee5c h\u1ed3i trong th\u00e1ng<\/td><\/tr> <tr><td>9 Th\u00e1ng 5, 2024<\/td><td>D\u1eef li\u1ec7u L\u00e2m s\u00e0ng<\/td><td>18,10 USD<\/td><td>+9,1%<\/td><td>\u0110\u1ea1t \u0111\u1ec9nh m\u1edbi<\/td><\/tr> <\/tbody> <\/table> <p><strong>Nh\u1eadn \u0110\u1ecbnh Xu H\u01b0\u1edbng<\/strong>: D\u1eef li\u1ec7u l\u00e2m s\u00e0ng t\u00edch c\u1ef1c v\u00e0 th\u00f4ng b\u00e1o h\u1ee3p t\u00e1c th\u01b0\u1eddng th\u00fac \u0111\u1ea9y c\u00e1c \u0111\u1ee3t t\u0103ng gi\u00e1 m\u1ea1nh h\u01a1n so v\u1edbi ch\u1ec9 b\u00e1o c\u00e1o thu nh\u1eadp. C\u00e1c bi\u1ebfn \u0111\u1ed9ng l\u1edbn nh\u1ea5t x\u1ea3y ra khi c\u00f4ng ty c\u00f4ng b\u1ed1 k\u1ebft qu\u1ea3 \u0111\u1ed9t ph\u00e1 trong l\u00e2m s\u00e0ng ho\u1eb7c c\u00e1c h\u1ee3p t\u00e1c l\u1edbn.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udd04 H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: T\u00e0u L\u01b0\u1ee3n C\u1ea3m X\u00fac C\u00f3 M\u1ee5c \u0110\u00edch<\/h2> <p>C\u1ed5 phi\u1ebfu Intellia \u0111\u00e3 tr\u1ea3i qua m\u1ed9t cu\u1ed9c phi\u00eau l\u01b0u t\u1eeb th\u00e1ng 2 \u0111\u1ebfn th\u00e1ng 8 n\u0103m 2025:<\/p> <p><strong>Th\u00e1ng 2 n\u0103m 2025<\/strong>: Giao d\u1ecbch quanh m\u1ee9c 14,20 USD sau k\u1ebft qu\u1ea3 h\u00e0ng n\u0103m m\u1ea1nh m\u1ebd<br\/> <strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: Gi\u1ea3m xu\u1ed1ng 12,80 USD do y\u1ebfu t\u1ed1 chung c\u1ee7a ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<br\/> <strong>Th\u00e1ng 4 n\u0103m 2025<\/strong>: Ph\u1ee5c h\u1ed3i l\u00ean 13,50 USD nh\u1edd c\u1eadp nh\u1eadt l\u00e2m s\u00e0ng t\u00edch c\u1ef1c<br\/> <strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: Gi\u1ea3m xu\u1ed1ng 11,40 USD sau b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd 1 g\u00e2y th\u1ea5t v\u1ecdng<br\/> <strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: \u1ed4n \u0111\u1ecbnh quanh v\u00f9ng 12,00 USD<br\/> <strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: T\u0103ng l\u00ean 13,19 USD nh\u1edd s\u1ef1 quan t\u00e2m tr\u1edf l\u1ea1i c\u1ee7a nh\u00e0 \u0111\u1ea7u t\u01b0<br\/> <strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: Hi\u1ec7n t\u1ea1i gi\u1ea3m v\u1ec1 m\u1ee9c 10,21 USD<\/p> <p>S\u1ef1 <strong>s\u1ee5t gi\u1ea3m 17%<\/strong> trong s\u00e1u th\u00e1ng c\u00f3 th\u1ec3 g\u00e2y lo ng\u1ea1i, nh\u01b0ng \u0111i\u1ec1u quan tr\u1ecdng l\u00e0 hi\u1ec3u b\u1ed1i c\u1ea3nh. C\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc, \u0111\u1eb7c bi\u1ec7t l\u00e0 nh\u1eefng c\u00f4ng ty trong giai \u0111o\u1ea1n l\u00e2m s\u00e0ng nh\u01b0 Intellia, tr\u1ea3i qua bi\u1ebfn \u0111\u1ed9ng cao d\u1ef1a tr\u00ean k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, c\u1eadp nh\u1eadt quy \u0111\u1ecbnh v\u00e0 t\u00e2m l\u00fd th\u1ecb tr\u01b0\u1eddng \u0111\u1ed1i v\u1edbi t\u00e0i s\u1ea3n r\u1ee7i ro.<\/p> <h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Qu\u1ef9 \u0110\u1ea1o T\u0103ng Tr\u01b0\u1edfng 2025-2030<\/h2> <p>D\u1ef1a tr\u00ean d\u1ef1 b\u00e1o hi\u1ec7n t\u1ea1i c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 c\u00e1c m\u1ed1c l\u00e2m s\u00e0ng, t\u01b0\u01a1ng lai c\u00f3 th\u1ec3 nh\u01b0 sau:<\/p> <p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: M\u1ee9c 16-18 USD (t\u0103ng 57-76% so v\u1edbi hi\u1ec7n t\u1ea1i)<br\/> <em>L\u00fd do: \u0110\u00e0 t\u00edch c\u1ef1c t\u1eeb thu nh\u1eadp qu\u00fd 3\/qu\u00fd 4 v\u00e0 ti\u1ebfn tri\u1ec3n l\u00e2m s\u00e0ng<\/em><\/p> <p><strong>M\u1ee5c ti\u00eau 2026<\/strong>: 22-25 USD (t\u0103ng tr\u01b0\u1edfng ti\u1ec1m n\u0103ng 115-145%)<br\/> <em>Ch\u1ea5t x\u00fac t\u00e1c: D\u1eef li\u1ec7u giai \u0111o\u1ea1n 3 v\u00e0 chu\u1ea9n b\u1ecb n\u1ed9p BLA<\/em><\/p> <p><strong>Tri\u1ec3n v\u1ecdng 2028<\/strong>: 35-45 USD (t\u0103ng 243-341%)<br\/> <em>\u0110\u1ed9ng l\u1ef1c: Kh\u1ea3 n\u0103ng ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i \u0111\u1ea7u ti\u00ean v\u00e0 m\u1edf r\u1ed9ng danh m\u1ee5c<\/em><\/p> <p><strong>T\u1ea7m nh\u00ecn 2030<\/strong>: 50-65 USD (l\u1ee3i nhu\u1eadn d\u00e0i h\u1ea1n 390-537%)<br\/> <em>N\u1ec1n t\u1ea3ng: Nhi\u1ec1u li\u1ec7u ph\u00e1p \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng<\/em><\/p> <p><strong>K\u1ebft lu\u1eadn<\/strong>: MUA M\u1ea0NH cho nh\u00e0 \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n c\u00f3 kh\u1ea3 n\u0103ng ch\u1ecbu r\u1ee7i ro. Gi\u00e1 hi\u1ec7n t\u1ea1i c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c nh\u1edb \u0111\u1ebfn nh\u01b0 m\u1ed9t c\u01a1 h\u1ed9i mua mang t\u00ednh th\u1ebf h\u1ec7 n\u1ebfu c\u00e1c li\u1ec7u ph\u00e1p ch\u1ec9nh s\u1eeda gen c\u1ee7a h\u1ecd \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t.<\/p> <h2>\u26a0\ufe0f \u0110\u00e1nh Gi\u00e1 R\u1ee7i Ro: \u0110i\u1ec1u H\u01b0\u1edbng Bi\u1ebfn \u0110\u1ed9ng C\u00f4ng Ngh\u1ec7 Sinh H\u1ecdc<\/h2> <h3>Nh\u1eefng R\u1ee7i Ro Ti\u1ec1m \u1ea8n<\/h3> <ul> <li><strong>Th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: 90% \u1ee9ng vi\u00ean thu\u1ed1c th\u1ea5t b\u1ea1i - th\u1ef1c t\u1ebf trong ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li> <li><strong>R\u00e0o c\u1ea3n ph\u00e1p l\u00fd<\/strong>: Ph\u00ea duy\u1ec7t FDA kh\u00f4ng bao gi\u1edd \u0111\u1ea3m b\u1ea3o, \u0111\u1eb7c bi\u1ec7t v\u1edbi c\u00f4ng ngh\u1ec7 m\u1edbi<\/li> <li><strong>Lo ng\u1ea1i v\u1ec1 d\u00f2ng ti\u1ec1n<\/strong>: M\u1eb7c d\u00f9 c\u00f3 v\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t 630,5 tri\u1ec7u USD<a href=\"https:\/\/www.stocktitan.net\/news\/NTLA\/intellia-therapeutics-announces-second-quarter-2025-financial-zqecci6852pr.html\">StockTitan<\/a>, chi ph\u00ed R&D cao v\u1eabn ti\u1ebfp di\u1ec5n<\/li> <li><strong>T\u00e2m l\u00fd th\u1ecb tr\u01b0\u1eddng<\/strong>: Ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u1eabn ch\u01b0a \u0111\u01b0\u1ee3c \u01b0a chu\u1ed9ng b\u1edfi nh\u00e0 \u0111\u1ea7u t\u01b0 chung<\/li> <li><strong>C\u1ea1nh tranh<\/strong>: C\u00e1c c\u00f4ng ty CRISPR kh\u00e1c nh\u01b0 CRISPR Therapeutics v\u00e0 Editas Medicine \u0111ang ti\u1ebfn tri\u1ec3n<\/li> <\/ul> <h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h3> <ul> <li><strong>T\u0103ng tr\u01b0\u1edfng doanh thu<\/strong>: Doanh thu h\u1ee3p t\u00e1c t\u0103ng 106% cho th\u1ea5y s\u1ee9c m\u1ea1nh \u0111\u1ed1i t\u00e1c<a href=\"https:\/\/www.nasdaq.com\/articles\/intellia-ntla-q2-revenue-jumps-106\">Nasdaq<\/a><\/li> <li><strong>Ti\u1ebfn tri\u1ec3n l\u00e2m s\u00e0ng<\/strong>: Th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 3 ti\u1ebfn tri\u1ec3n nhanh h\u01a1n d\u1ef1 ki\u1ebfn<\/li> <li><strong>H\u1ed7 tr\u1ee3 t\u1ed5 ch\u1ee9c<\/strong>: ARK Investment mua 560.600 c\u1ed5 phi\u1ebfu tr\u1ecb gi\u00e1 7,17 tri\u1ec7u USD<a href=\"https:\/\/www.ainvest.com\/news\/cathie-wood-ark-investment-purchases-560k-shares-intellia-therapeutics-2508\/\">AInvest<\/a><\/li> <li><strong>Th\u1eddi gian s\u1eed d\u1ee5ng ti\u1ec1n m\u1eb7t<\/strong>: Qu\u1ef9 \u0111\u1ee7 cho ho\u1ea1t \u0111\u1ed9ng \u0111\u1ebfn n\u1eeda \u0111\u1ea7u n\u0103m 2027, t\u1ea1o s\u1ef1 \u1ed5n \u0111\u1ecbnh<\/li> <li><strong>Xu h\u01b0\u1edbng ng\u00e0nh<\/strong>: Ch\u1ec9nh s\u1eeda gen \u0111\u01b0\u1ee3c ch\u1ea5p nh\u1eadn quy \u0111\u1ecbnh ng\u00e0y c\u00e0ng nhi\u1ec1u<\/li> <\/ul> <h2>\ud83d\udcca Ph\u00e2n T\u00edch T\u00e1c \u0110\u1ed9ng Tin T\u1ee9c G\u1ea7n \u0110\u00e2y<\/h2> <p>B\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd 2 ng\u00e0y 7 th\u00e1ng 8 n\u0103m 2025 cung c\u1ea5p nhi\u1ec1u \u0111i\u1ec3m d\u1eef li\u1ec7u t\u00edch c\u1ef1c ch\u01b0a \u0111\u01b0\u1ee3c th\u1ecb tr\u01b0\u1eddng \u0111\u00e1nh gi\u00e1 \u0111\u1ea7y \u0111\u1ee7:<\/p> <ul> <li><strong>S\u1ee9c m\u1ea1nh t\u00e0i ch\u00ednh<\/strong>: V\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t 630,5 tri\u1ec7u USD lo\u1ea1i b\u1ecf lo ng\u1ea1i pha lo\u00e3ng ng\u1eafn h\u1ea1n<\/li> <li><strong>Doanh thu v\u01b0\u1ee3t k\u1ef3 v\u1ecdng<\/strong>: 14,2 tri\u1ec7u USD so v\u1edbi 11,9 tri\u1ec7u USD d\u1ef1 ki\u1ebfn cho th\u1ea5y gi\u00e1 tr\u1ecb h\u1ee3p t\u00e1c<\/li> <li><strong>Th\u00fac \u0111\u1ea9y l\u00e2m s\u00e0ng<\/strong>: Th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 3 ti\u1ebfn tri\u1ec3n nhanh h\u01a1n d\u1ef1 ki\u1ebfn<\/li> <li><strong>C\u1ea3i thi\u1ec7n hi\u1ec7u qu\u1ea3<\/strong>: T\u00e1i c\u1ea5u tr\u00fac ho\u00e0n th\u00e0nh, t\u1eadp trung ngu\u1ed3n l\u1ef1c v\u00e0o c\u00e1c ch\u01b0\u01a1ng tr\u00ecnh ch\u1ee7 \u0111\u1ea1o<\/li> <\/ul> <p>Ph\u1ea3n \u1ee9ng y\u1ebfu c\u1ee7a th\u1ecb tr\u01b0\u1eddng c\u00f3 th\u1ec3 ph\u1ea3n \u00e1nh s\u1ef1 y\u1ebfu k\u00e9m chung c\u1ee7a ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc h\u01a1n l\u00e0 lo ng\u1ea1i ri\u00eang v\u1ec1 c\u00f4ng ty. \u0110i\u1ec1u n\u00e0y t\u1ea1o c\u01a1 h\u1ed9i ti\u1ec1m n\u0103ng cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 tinh t\u01b0\u1eddng.<\/p> <h2>\ud83c\udfaf K\u1ebf Ho\u1ea1ch H\u00e0nh \u0110\u1ed9ng Cho Nh\u00e0 Giao D\u1ecbch M\u1edbi H\u00f4m Nay<\/h2> <ol> <li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: Ch\u1ec9 ph\u00e2n b\u1ed5 2-5% danh m\u1ee5c cho c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li> <li><strong>Trung b\u00ecnh gi\u00e1<\/strong>: Mua theo t\u1eebng ph\u1ea7n thay v\u00ec m\u1ed9t l\u1ea7n - c\u00f3 th\u1ec3 500 USD m\u1ed7i th\u00e1ng<\/li> <li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/strong>: Th\u00f4ng b\u00e1o \u1edf m\u1ee9c 9,50 USD, 11,00 USD v\u00e0 13,00 USD \u0111\u1ec3 v\u00e0o l\u1ec7nh chi\u1ebfn l\u01b0\u1ee3c<\/li> <li><strong>T\u01b0 duy d\u00e0i h\u1ea1n<\/strong>: L\u00ean k\u1ebf ho\u1ea1ch gi\u1eef \u00edt nh\u1ea5t 3-5 n\u0103m \u0111\u1ec3 ch\u1edd ph\u00e1t tri\u1ec3n l\u00e2m s\u00e0ng<\/li> <li><strong>Ki\u1ec3m tra th\u1ef1c t\u1ebf h\u00e0i h\u01b0\u1edbc<\/strong>: \"Giao d\u1ecbch NTLA gi\u1ed1ng nh\u01b0 xem s\u01a1n kh\u00f4... n\u1ebfu s\u01a1n \u0111\u00f3 c\u00f3 th\u1ec3 \u0111\u1ed9t ng\u1ed9t ch\u1eefa b\u1ec7nh v\u00e0 l\u00e0m b\u1ea1n gi\u00e0u qua \u0111\u00eam. C\u1ea7n ki\u00ean nh\u1eabn!\"<\/li> <\/ol> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Intellia Therapeutics, Inc. (NTLA) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o c\u00f3 danh s\u00e1ch NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu l\u1ebb<\/td><\/tr> <tr><td>2<\/td><td>Ho\u00e0n th\u00e0nh thi\u1ebft l\u1eadp t\u00e0i kho\u1ea3n<\/td><td>Cung c\u1ea5p th\u00f4ng tin nh\u1eadn d\u1ea1ng v\u00e0 t\u00e0i ch\u00ednh<\/td><\/tr> <tr><td>3<\/td><td>N\u1ea1p ti\u1ec1n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i khi r\u1ee7i ro<\/td><\/tr> <tr><td>4<\/td><td>T\u00ecm ki\u1ebfm \"NTLA\"<\/td><td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n \u0111\u1ec3 c\u00f3 k\u1ebft qu\u1ea3 ch\u00ednh x\u00e1c<\/td><\/tr> <tr><td>5<\/td><td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td><td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o<\/td><\/tr> <tr><td>6<\/td><td>Xem l\u1ea1i chi ti\u1ebft l\u1ec7nh<\/td><td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng v\u00e0 ng\u00e0y thanh to\u00e1n<\/td><\/tr> <tr><td>7<\/td><td>Th\u1ef1c hi\u1ec7n mua<\/td><td>X\u00e1c nh\u1eadn l\u1ec7nh v\u00e0 theo d\u00f5i th\u1ef1c hi\u1ec7n<\/td><\/tr> <tr><td>8<\/td><td>\u0110\u1eb7t theo d\u00f5i danh m\u1ee5c<\/td><td>Thi\u1ebft l\u1eadp c\u1ea3nh b\u00e1o gi\u00e1 v\u00e0 gi\u00e1m s\u00e1t hi\u1ec7u su\u1ea5t<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Thu H\u00fat Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf gi\u00fap vi\u1ec7c v\u00e0o v\u1ecb th\u1ebf nh\u01b0 NTLA tr\u1edf n\u00ean d\u1ec5 d\u00e0ng h\u01a1n:<\/p> <ul> <li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u<\/strong>: Ch\u1ec9 5 USD cho ph\u00e9p th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro th\u1ea5p<\/li> <li><strong>X\u00e1c minh nhanh<\/strong>: Quy tr\u00ecnh KYC m\u1ed9t t\u00e0i li\u1ec7u gi\u00fap k\u00edch ho\u1ea1t t\u00e0i kho\u1ea3n nhanh ch\u00f3ng<\/li> <li><strong>\u0110a d\u1ea1ng ph\u01b0\u01a1ng th\u1ee9c n\u1ea1p r\u00fat<\/strong>: H\u00e0ng tr\u0103m ph\u01b0\u01a1ng th\u1ee9c cung c\u1ea5p s\u1ef1 linh ho\u1ea1t<\/li> <li><strong>C\u1ed5 phi\u1ebfu l\u1ebb<\/strong>: Kh\u1ea3 n\u0103ng mua c\u1ed5 phi\u1ebfu ph\u1ea7n l\u1ebb gi\u00fap ti\u1ebfp c\u1eadn c\u1ed5 phi\u1ebfu gi\u00e1 cao<\/li> <li><strong>T\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c<\/strong>: <a href=\"\/blog\">Blog Pocket Option<\/a> cung c\u1ea5p c\u01a1 h\u1ed9i h\u1ecdc t\u1eadp li\u00ean t\u1ee5c<\/li> <\/ul> <p>Nh\u1eefng t\u00ednh n\u0103ng n\u00e0y \u0111\u1eb7c bi\u1ec7t c\u00f3 gi\u00e1 tr\u1ecb khi \u0111\u1ea7u t\u01b0 v\u00e0o c\u00e1c ng\u00e0nh bi\u1ebfn \u0111\u1ed9ng nh\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc, n\u01a1i vi\u1ec7c \u0111\u1ecbnh k\u00edch th\u01b0\u1edbc v\u1ecb th\u1ebf v\u00e0 qu\u1ea3n l\u00fd r\u1ee7i ro r\u1ea5t quan tr\u1ecdng.<\/p> <h2>\ud83e\uddec Intellia Therapeutics N\u0103m 2025: Ti\u00ean Phong Ch\u1ec9nh S\u1eeda Gen<\/h2> <p>Intellia l\u00e0 c\u00f4ng ty d\u1eabn \u0111\u1ea7u trong l\u0129nh v\u1ef1c li\u1ec7u ph\u00e1p d\u1ef1a tr\u00ean CRISPR, ph\u00e1t tri\u1ec3n c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb c\u00f3 th\u1ec3 c\u00e1ch m\u1ea1ng h\u00f3a c\u00e1ch ch\u00fang ta x\u1eed l\u00fd c\u00e1c b\u1ec7nh di truy\u1ec1n. C\u00f4ng ty t\u1eadp trung v\u00e0o c\u1ea3 ph\u01b0\u01a1ng ph\u00e1p in vivo (trong c\u01a1 th\u1ec3) v\u00e0 ex vivo (ngo\u00e0i c\u01a1 th\u1ec3) gi\u00fap h\u1ecd c\u00f3 v\u1ecb th\u1ebf \u0111\u1ed9c \u0111\u00e1o trong l\u0129nh v\u1ef1c ch\u1ec9nh s\u1eeda gen<a href=\"https:\/\/crisprmedicinenews.com\/company\/card\/intellia-therapeutics\/\">CRISPR Medicine News<\/a>.<\/p> <p>C\u00e1c ch\u01b0\u01a1ng tr\u00ecnh ti\u00ean ti\u1ebfn nh\u1ea5t c\u1ee7a h\u1ecd nh\u1eafm \u0111\u1ebfn ph\u00f9 m\u1ea1ch di truy\u1ec1n v\u00e0 amyloidosis transthyretin - c\u00e1c b\u1ec7nh \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u00e0ng ng\u00e0n b\u1ec7nh nh\u00e2n tr\u00ean to\u00e0n th\u1ebf gi\u1edbi v\u1edbi l\u1ef1a ch\u1ecdn \u0111i\u1ec1u tr\u1ecb h\u1ea1n ch\u1ebf. Vi\u1ec7c t\u00e1i c\u1ea5u tr\u00fac c\u00f4ng ty \u0111\u1ea7u n\u0103m 2025, d\u00f9 \u0111au \u0111\u1edbn v\u1edbi vi\u1ec7c gi\u1ea3m 27% nh\u00e2n s\u1ef1<a href=\"https:\/\/www.fiercebiotech.com\/biotech\/intellia-citing-challenging-market-environment-culls-27-staff-it-takes-ax-pipeline\">Fierce Biotech<\/a>, th\u1ef1c s\u1ef1 \u0111\u00e3 c\u1ee7ng c\u1ed1 s\u1ef1 t\u1eadp trung v\u00e0o c\u00e1c t\u00e0i s\u1ea3n giai \u0111o\u1ea1n cu\u1ed1i \u0111\u1ea7y h\u1ee9a h\u1eb9n n\u00e0y.<\/p> <p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb n\u0103m 2025<\/strong>: Tr\u1ee5 s\u1edf ch\u00ednh c\u1ee7a Intellia t\u1ea1i Cambridge c\u00f3 m\u1ed9t \"B\u1ee9c t\u01b0\u1eddng Danh V\u1ecdng CRISPR\" tr\u01b0ng b\u00e0y c\u00e1c chu\u1ed7i DNA \u0111\u01b0\u1ee3c ch\u1ec9nh s\u1eeda b\u1edfi c\u00f4ng ngh\u1ec7 c\u1ee7a h\u1ecd \u0111\u00e3 d\u1eabn \u0111\u1ebfn c\u00e1c \u0111\u1ed9t ph\u00e1 \u0111i\u1ec1u tr\u1ecb - m\u1ed9t l\u1eddi nh\u1eafc nh\u1edf li\u00ean t\u1ee5c cho nh\u00e2n vi\u00ean r\u1eb1ng h\u1ecd \u0111ang th\u1ef1c s\u1ef1 vi\u1ebft l\u1ea1i m\u00e3 gen \u0111\u1ec3 c\u1ee9u s\u1ed1ng con ng\u01b0\u1eddi.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 V\u1ecb Tr\u00ed Th\u1ecb Tr\u01b0\u1eddng Hi\u1ec7n T\u1ea1i v\u00e0 Chi\u1ebfn L\u01b0\u1ee3c Giao D\u1ecbch<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 20 th\u00e1ng 8 n\u0103m 2025, Intellia Therapeutics (NTLA) \u0111ang giao d\u1ecbch \u1edf m\u1ee9c <strong>10,21 USD<\/strong>, \u0111\u01b0\u1ee3c nhi\u1ec1u nh\u00e0 ph\u00e2n t\u00edch xem l\u00e0 c\u01a1 h\u1ed9i mua ti\u1ec1m n\u0103ng trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc bi\u1ebfn \u0111\u1ed9ng. C\u1ed5 phi\u1ebfu \u0111\u00e3 ch\u1ecbu \u00e1p l\u1ef1c \u0111\u00e1ng k\u1ec3 g\u1ea7n \u0111\u00e2y, nh\u01b0ng \u0111i\u1ec1u n\u00e0y c\u00f3 th\u1ec3 l\u00e0 \u0111i\u1ec3m v\u00e0o h\u1ea5p d\u1eabn cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n.<\/p>\n<p><strong>\u0110\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: ng\u00e0y 6 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y quan tr\u1ecdng ti\u1ebfp theo khi Intellia c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c b\u00e1o c\u00e1o n\u00e0y th\u01b0\u1eddng l\u00e0m c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh. Nh\u00ecn l\u1ea1i b\u00e1o c\u00e1o qu\u00fd 2 ng\u00e0y 7 th\u00e1ng 8 n\u0103m 2025, c\u00f4ng ty \u0111\u00e3 b\u00e1o c\u00e1o k\u1ebft qu\u1ea3 \u1ea5n t\u01b0\u1ee3ng v\u1edbi doanh thu h\u1ee3p t\u00e1c t\u0103ng <strong>106%<\/strong> l\u00ean 14,2 tri\u1ec7u USD, v\u01b0\u1ee3t k\u1ef3 v\u1ecdng c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch<a href=\"https:\/\/www.aol.com\/finance\/intellia-ntla-q2-revenue-jumps-152350711.html\">AOL Finance<\/a>.<\/p>\n<h3>Ph\u00e2n T\u00edch T\u00e1c \u0110\u1ed9ng L\u1ecbch S\u1eed Thu Nh\u1eadp<\/h3>\n<table>\n<thead>\n<tr>\n<th>Ng\u00e0y<\/th>\n<th>S\u1ef1 ki\u1ec7n<\/th>\n<th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th>\n<th>Thay \u0110\u1ed5i Sau Tin<\/th>\n<th>Th\u1eddi Gian<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>7 Th\u00e1ng 8, 2025<\/td>\n<td>B\u00e1o c\u00e1o Qu\u00fd 2<\/td>\n<td>11,37 USD<\/td>\n<td>+0,9% (1 ng\u00e0y)<\/td>\n<td>\u1ed4n \u0111\u1ecbnh nhanh<\/td>\n<\/tr>\n<tr>\n<td>8 Th\u00e1ng 5, 2025<\/td>\n<td>K\u1ebft qu\u1ea3 Qu\u00fd 1<\/td>\n<td>12,50 USD<\/td>\n<td>-8,4%<\/td>\n<td>S\u1ee5t gi\u1ea3m k\u00e9o d\u00e0i m\u1ed9t tu\u1ea7n<\/td>\n<\/tr>\n<tr>\n<td>6 Th\u00e1ng 2, 2025<\/td>\n<td>B\u00e1o c\u00e1o H\u00e0ng n\u0103m<\/td>\n<td>14,20 USD<\/td>\n<td>+3,5%<\/td>\n<td>T\u0103ng gi\u00e1 3 ng\u00e0y<\/td>\n<\/tr>\n<tr>\n<td>7 Th\u00e1ng 11, 2024<\/td>\n<td>Tin \u0110\u1ed1i T\u00e1c<\/td>\n<td>15,80 USD<\/td>\n<td>+6,2%<\/td>\n<td>T\u0103ng tr\u01b0\u1edfng b\u1ec1n v\u1eefng<\/td>\n<\/tr>\n<tr>\n<td>8 Th\u00e1ng 8, 2024<\/td>\n<td>Qu\u00fd 2 N\u0103m 2024<\/td>\n<td>16,40 USD<\/td>\n<td>-4,8%<\/td>\n<td>Ph\u1ee5c h\u1ed3i trong th\u00e1ng<\/td>\n<\/tr>\n<tr>\n<td>9 Th\u00e1ng 5, 2024<\/td>\n<td>D\u1eef li\u1ec7u L\u00e2m s\u00e0ng<\/td>\n<td>18,10 USD<\/td>\n<td>+9,1%<\/td>\n<td>\u0110\u1ea1t \u0111\u1ec9nh m\u1edbi<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Nh\u1eadn \u0110\u1ecbnh Xu H\u01b0\u1edbng<\/strong>: D\u1eef li\u1ec7u l\u00e2m s\u00e0ng t\u00edch c\u1ef1c v\u00e0 th\u00f4ng b\u00e1o h\u1ee3p t\u00e1c th\u01b0\u1eddng th\u00fac \u0111\u1ea9y c\u00e1c \u0111\u1ee3t t\u0103ng gi\u00e1 m\u1ea1nh h\u01a1n so v\u1edbi ch\u1ec9 b\u00e1o c\u00e1o thu nh\u1eadp. C\u00e1c bi\u1ebfn \u0111\u1ed9ng l\u1edbn nh\u1ea5t x\u1ea3y ra khi c\u00f4ng ty c\u00f4ng b\u1ed1 k\u1ebft qu\u1ea3 \u0111\u1ed9t ph\u00e1 trong l\u00e2m s\u00e0ng ho\u1eb7c c\u00e1c h\u1ee3p t\u00e1c l\u1edbn.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd04 H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: T\u00e0u L\u01b0\u1ee3n C\u1ea3m X\u00fac C\u00f3 M\u1ee5c \u0110\u00edch<\/h2>\n<p>C\u1ed5 phi\u1ebfu Intellia \u0111\u00e3 tr\u1ea3i qua m\u1ed9t cu\u1ed9c phi\u00eau l\u01b0u t\u1eeb th\u00e1ng 2 \u0111\u1ebfn th\u00e1ng 8 n\u0103m 2025:<\/p>\n<p><strong>Th\u00e1ng 2 n\u0103m 2025<\/strong>: Giao d\u1ecbch quanh m\u1ee9c 14,20 USD sau k\u1ebft qu\u1ea3 h\u00e0ng n\u0103m m\u1ea1nh m\u1ebd<br \/> <strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: Gi\u1ea3m xu\u1ed1ng 12,80 USD do y\u1ebfu t\u1ed1 chung c\u1ee7a ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<br \/> <strong>Th\u00e1ng 4 n\u0103m 2025<\/strong>: Ph\u1ee5c h\u1ed3i l\u00ean 13,50 USD nh\u1edd c\u1eadp nh\u1eadt l\u00e2m s\u00e0ng t\u00edch c\u1ef1c<br \/> <strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: Gi\u1ea3m xu\u1ed1ng 11,40 USD sau b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd 1 g\u00e2y th\u1ea5t v\u1ecdng<br \/> <strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: \u1ed4n \u0111\u1ecbnh quanh v\u00f9ng 12,00 USD<br \/> <strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: T\u0103ng l\u00ean 13,19 USD nh\u1edd s\u1ef1 quan t\u00e2m tr\u1edf l\u1ea1i c\u1ee7a nh\u00e0 \u0111\u1ea7u t\u01b0<br \/> <strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: Hi\u1ec7n t\u1ea1i gi\u1ea3m v\u1ec1 m\u1ee9c 10,21 USD<\/p>\n<p>S\u1ef1 <strong>s\u1ee5t gi\u1ea3m 17%<\/strong> trong s\u00e1u th\u00e1ng c\u00f3 th\u1ec3 g\u00e2y lo ng\u1ea1i, nh\u01b0ng \u0111i\u1ec1u quan tr\u1ecdng l\u00e0 hi\u1ec3u b\u1ed1i c\u1ea3nh. C\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc, \u0111\u1eb7c bi\u1ec7t l\u00e0 nh\u1eefng c\u00f4ng ty trong giai \u0111o\u1ea1n l\u00e2m s\u00e0ng nh\u01b0 Intellia, tr\u1ea3i qua bi\u1ebfn \u0111\u1ed9ng cao d\u1ef1a tr\u00ean k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, c\u1eadp nh\u1eadt quy \u0111\u1ecbnh v\u00e0 t\u00e2m l\u00fd th\u1ecb tr\u01b0\u1eddng \u0111\u1ed1i v\u1edbi t\u00e0i s\u1ea3n r\u1ee7i ro.<\/p>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Qu\u1ef9 \u0110\u1ea1o T\u0103ng Tr\u01b0\u1edfng 2025-2030<\/h2>\n<p>D\u1ef1a tr\u00ean d\u1ef1 b\u00e1o hi\u1ec7n t\u1ea1i c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 c\u00e1c m\u1ed1c l\u00e2m s\u00e0ng, t\u01b0\u01a1ng lai c\u00f3 th\u1ec3 nh\u01b0 sau:<\/p>\n<p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: M\u1ee9c 16-18 USD (t\u0103ng 57-76% so v\u1edbi hi\u1ec7n t\u1ea1i)<br \/> <em>L\u00fd do: \u0110\u00e0 t\u00edch c\u1ef1c t\u1eeb thu nh\u1eadp qu\u00fd 3\/qu\u00fd 4 v\u00e0 ti\u1ebfn tri\u1ec3n l\u00e2m s\u00e0ng<\/em><\/p>\n<p><strong>M\u1ee5c ti\u00eau 2026<\/strong>: 22-25 USD (t\u0103ng tr\u01b0\u1edfng ti\u1ec1m n\u0103ng 115-145%)<br \/> <em>Ch\u1ea5t x\u00fac t\u00e1c: D\u1eef li\u1ec7u giai \u0111o\u1ea1n 3 v\u00e0 chu\u1ea9n b\u1ecb n\u1ed9p BLA<\/em><\/p>\n<p><strong>Tri\u1ec3n v\u1ecdng 2028<\/strong>: 35-45 USD (t\u0103ng 243-341%)<br \/> <em>\u0110\u1ed9ng l\u1ef1c: Kh\u1ea3 n\u0103ng ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i \u0111\u1ea7u ti\u00ean v\u00e0 m\u1edf r\u1ed9ng danh m\u1ee5c<\/em><\/p>\n<p><strong>T\u1ea7m nh\u00ecn 2030<\/strong>: 50-65 USD (l\u1ee3i nhu\u1eadn d\u00e0i h\u1ea1n 390-537%)<br \/> <em>N\u1ec1n t\u1ea3ng: Nhi\u1ec1u li\u1ec7u ph\u00e1p \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng<\/em><\/p>\n<p><strong>K\u1ebft lu\u1eadn<\/strong>: MUA M\u1ea0NH cho nh\u00e0 \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n c\u00f3 kh\u1ea3 n\u0103ng ch\u1ecbu r\u1ee7i ro. Gi\u00e1 hi\u1ec7n t\u1ea1i c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c nh\u1edb \u0111\u1ebfn nh\u01b0 m\u1ed9t c\u01a1 h\u1ed9i mua mang t\u00ednh th\u1ebf h\u1ec7 n\u1ebfu c\u00e1c li\u1ec7u ph\u00e1p ch\u1ec9nh s\u1eeda gen c\u1ee7a h\u1ecd \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t.<\/p>\n<h2>\u26a0\ufe0f \u0110\u00e1nh Gi\u00e1 R\u1ee7i Ro: \u0110i\u1ec1u H\u01b0\u1edbng Bi\u1ebfn \u0110\u1ed9ng C\u00f4ng Ngh\u1ec7 Sinh H\u1ecdc<\/h2>\n<h3>Nh\u1eefng R\u1ee7i Ro Ti\u1ec1m \u1ea8n<\/h3>\n<ul>\n<li><strong>Th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: 90% \u1ee9ng vi\u00ean thu\u1ed1c th\u1ea5t b\u1ea1i &#8211; th\u1ef1c t\u1ebf trong ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li>\n<li><strong>R\u00e0o c\u1ea3n ph\u00e1p l\u00fd<\/strong>: Ph\u00ea duy\u1ec7t FDA kh\u00f4ng bao gi\u1edd \u0111\u1ea3m b\u1ea3o, \u0111\u1eb7c bi\u1ec7t v\u1edbi c\u00f4ng ngh\u1ec7 m\u1edbi<\/li>\n<li><strong>Lo ng\u1ea1i v\u1ec1 d\u00f2ng ti\u1ec1n<\/strong>: M\u1eb7c d\u00f9 c\u00f3 v\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t 630,5 tri\u1ec7u USD<a href=\"https:\/\/www.stocktitan.net\/news\/NTLA\/intellia-therapeutics-announces-second-quarter-2025-financial-zqecci6852pr.html\">StockTitan<\/a>, chi ph\u00ed R&#038;D cao v\u1eabn ti\u1ebfp di\u1ec5n<\/li>\n<li><strong>T\u00e2m l\u00fd th\u1ecb tr\u01b0\u1eddng<\/strong>: Ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u1eabn ch\u01b0a \u0111\u01b0\u1ee3c \u01b0a chu\u1ed9ng b\u1edfi nh\u00e0 \u0111\u1ea7u t\u01b0 chung<\/li>\n<li><strong>C\u1ea1nh tranh<\/strong>: C\u00e1c c\u00f4ng ty CRISPR kh\u00e1c nh\u01b0 CRISPR Therapeutics v\u00e0 Editas Medicine \u0111ang ti\u1ebfn tri\u1ec3n<\/li>\n<\/ul>\n<h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h3>\n<ul>\n<li><strong>T\u0103ng tr\u01b0\u1edfng doanh thu<\/strong>: Doanh thu h\u1ee3p t\u00e1c t\u0103ng 106% cho th\u1ea5y s\u1ee9c m\u1ea1nh \u0111\u1ed1i t\u00e1c<a href=\"https:\/\/www.nasdaq.com\/articles\/intellia-ntla-q2-revenue-jumps-106\">Nasdaq<\/a><\/li>\n<li><strong>Ti\u1ebfn tri\u1ec3n l\u00e2m s\u00e0ng<\/strong>: Th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 3 ti\u1ebfn tri\u1ec3n nhanh h\u01a1n d\u1ef1 ki\u1ebfn<\/li>\n<li><strong>H\u1ed7 tr\u1ee3 t\u1ed5 ch\u1ee9c<\/strong>: ARK Investment mua 560.600 c\u1ed5 phi\u1ebfu tr\u1ecb gi\u00e1 7,17 tri\u1ec7u USD<a href=\"https:\/\/www.ainvest.com\/news\/cathie-wood-ark-investment-purchases-560k-shares-intellia-therapeutics-2508\/\">AInvest<\/a><\/li>\n<li><strong>Th\u1eddi gian s\u1eed d\u1ee5ng ti\u1ec1n m\u1eb7t<\/strong>: Qu\u1ef9 \u0111\u1ee7 cho ho\u1ea1t \u0111\u1ed9ng \u0111\u1ebfn n\u1eeda \u0111\u1ea7u n\u0103m 2027, t\u1ea1o s\u1ef1 \u1ed5n \u0111\u1ecbnh<\/li>\n<li><strong>Xu h\u01b0\u1edbng ng\u00e0nh<\/strong>: Ch\u1ec9nh s\u1eeda gen \u0111\u01b0\u1ee3c ch\u1ea5p nh\u1eadn quy \u0111\u1ecbnh ng\u00e0y c\u00e0ng nhi\u1ec1u<\/li>\n<\/ul>\n<h2>\ud83d\udcca Ph\u00e2n T\u00edch T\u00e1c \u0110\u1ed9ng Tin T\u1ee9c G\u1ea7n \u0110\u00e2y<\/h2>\n<p>B\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd 2 ng\u00e0y 7 th\u00e1ng 8 n\u0103m 2025 cung c\u1ea5p nhi\u1ec1u \u0111i\u1ec3m d\u1eef li\u1ec7u t\u00edch c\u1ef1c ch\u01b0a \u0111\u01b0\u1ee3c th\u1ecb tr\u01b0\u1eddng \u0111\u00e1nh gi\u00e1 \u0111\u1ea7y \u0111\u1ee7:<\/p>\n<ul>\n<li><strong>S\u1ee9c m\u1ea1nh t\u00e0i ch\u00ednh<\/strong>: V\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t 630,5 tri\u1ec7u USD lo\u1ea1i b\u1ecf lo ng\u1ea1i pha lo\u00e3ng ng\u1eafn h\u1ea1n<\/li>\n<li><strong>Doanh thu v\u01b0\u1ee3t k\u1ef3 v\u1ecdng<\/strong>: 14,2 tri\u1ec7u USD so v\u1edbi 11,9 tri\u1ec7u USD d\u1ef1 ki\u1ebfn cho th\u1ea5y gi\u00e1 tr\u1ecb h\u1ee3p t\u00e1c<\/li>\n<li><strong>Th\u00fac \u0111\u1ea9y l\u00e2m s\u00e0ng<\/strong>: Th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n 3 ti\u1ebfn tri\u1ec3n nhanh h\u01a1n d\u1ef1 ki\u1ebfn<\/li>\n<li><strong>C\u1ea3i thi\u1ec7n hi\u1ec7u qu\u1ea3<\/strong>: T\u00e1i c\u1ea5u tr\u00fac ho\u00e0n th\u00e0nh, t\u1eadp trung ngu\u1ed3n l\u1ef1c v\u00e0o c\u00e1c ch\u01b0\u01a1ng tr\u00ecnh ch\u1ee7 \u0111\u1ea1o<\/li>\n<\/ul>\n<p>Ph\u1ea3n \u1ee9ng y\u1ebfu c\u1ee7a th\u1ecb tr\u01b0\u1eddng c\u00f3 th\u1ec3 ph\u1ea3n \u00e1nh s\u1ef1 y\u1ebfu k\u00e9m chung c\u1ee7a ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc h\u01a1n l\u00e0 lo ng\u1ea1i ri\u00eang v\u1ec1 c\u00f4ng ty. \u0110i\u1ec1u n\u00e0y t\u1ea1o c\u01a1 h\u1ed9i ti\u1ec1m n\u0103ng cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 tinh t\u01b0\u1eddng.<\/p>\n<h2>\ud83c\udfaf K\u1ebf Ho\u1ea1ch H\u00e0nh \u0110\u1ed9ng Cho Nh\u00e0 Giao D\u1ecbch M\u1edbi H\u00f4m Nay<\/h2>\n<ol>\n<li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: Ch\u1ec9 ph\u00e2n b\u1ed5 2-5% danh m\u1ee5c cho c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li>\n<li><strong>Trung b\u00ecnh gi\u00e1<\/strong>: Mua theo t\u1eebng ph\u1ea7n thay v\u00ec m\u1ed9t l\u1ea7n &#8211; c\u00f3 th\u1ec3 500 USD m\u1ed7i th\u00e1ng<\/li>\n<li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/strong>: Th\u00f4ng b\u00e1o \u1edf m\u1ee9c 9,50 USD, 11,00 USD v\u00e0 13,00 USD \u0111\u1ec3 v\u00e0o l\u1ec7nh chi\u1ebfn l\u01b0\u1ee3c<\/li>\n<li><strong>T\u01b0 duy d\u00e0i h\u1ea1n<\/strong>: L\u00ean k\u1ebf ho\u1ea1ch gi\u1eef \u00edt nh\u1ea5t 3-5 n\u0103m \u0111\u1ec3 ch\u1edd ph\u00e1t tri\u1ec3n l\u00e2m s\u00e0ng<\/li>\n<li><strong>Ki\u1ec3m tra th\u1ef1c t\u1ebf h\u00e0i h\u01b0\u1edbc<\/strong>: &#8220;Giao d\u1ecbch NTLA gi\u1ed1ng nh\u01b0 xem s\u01a1n kh\u00f4&#8230; n\u1ebfu s\u01a1n \u0111\u00f3 c\u00f3 th\u1ec3 \u0111\u1ed9t ng\u1ed9t ch\u1eefa b\u1ec7nh v\u00e0 l\u00e0m b\u1ea1n gi\u00e0u qua \u0111\u00eam. C\u1ea7n ki\u00ean nh\u1eabn!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Intellia Therapeutics, Inc. (NTLA) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o c\u00f3 danh s\u00e1ch NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu l\u1ebb<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n th\u00e0nh thi\u1ebft l\u1eadp t\u00e0i kho\u1ea3n<\/td>\n<td>Cung c\u1ea5p th\u00f4ng tin nh\u1eadn d\u1ea1ng v\u00e0 t\u00e0i ch\u00ednh<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>N\u1ea1p ti\u1ec1n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i khi r\u1ee7i ro<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>T\u00ecm ki\u1ebfm &#8220;NTLA&#8221;<\/td>\n<td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n \u0111\u1ec3 c\u00f3 k\u1ebft qu\u1ea3 ch\u00ednh x\u00e1c<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td>\n<td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Xem l\u1ea1i chi ti\u1ebft l\u1ec7nh<\/td>\n<td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng v\u00e0 ng\u00e0y thanh to\u00e1n<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Th\u1ef1c hi\u1ec7n mua<\/td>\n<td>X\u00e1c nh\u1eadn l\u1ec7nh v\u00e0 theo d\u00f5i th\u1ef1c hi\u1ec7n<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>\u0110\u1eb7t theo d\u00f5i danh m\u1ee5c<\/td>\n<td>Thi\u1ebft l\u1eadp c\u1ea3nh b\u00e1o gi\u00e1 v\u00e0 gi\u00e1m s\u00e1t hi\u1ec7u su\u1ea5t<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Thu H\u00fat Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf gi\u00fap vi\u1ec7c v\u00e0o v\u1ecb th\u1ebf nh\u01b0 NTLA tr\u1edf n\u00ean d\u1ec5 d\u00e0ng h\u01a1n:<\/p>\n<ul>\n<li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u<\/strong>: Ch\u1ec9 5 USD cho ph\u00e9p th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro th\u1ea5p<\/li>\n<li><strong>X\u00e1c minh nhanh<\/strong>: Quy tr\u00ecnh KYC m\u1ed9t t\u00e0i li\u1ec7u gi\u00fap k\u00edch ho\u1ea1t t\u00e0i kho\u1ea3n nhanh ch\u00f3ng<\/li>\n<li><strong>\u0110a d\u1ea1ng ph\u01b0\u01a1ng th\u1ee9c n\u1ea1p r\u00fat<\/strong>: H\u00e0ng tr\u0103m ph\u01b0\u01a1ng th\u1ee9c cung c\u1ea5p s\u1ef1 linh ho\u1ea1t<\/li>\n<li><strong>C\u1ed5 phi\u1ebfu l\u1ebb<\/strong>: Kh\u1ea3 n\u0103ng mua c\u1ed5 phi\u1ebfu ph\u1ea7n l\u1ebb gi\u00fap ti\u1ebfp c\u1eadn c\u1ed5 phi\u1ebfu gi\u00e1 cao<\/li>\n<li><strong>T\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c<\/strong>: <a href=\"\/blog\">Blog Pocket Option<\/a> cung c\u1ea5p c\u01a1 h\u1ed9i h\u1ecdc t\u1eadp li\u00ean t\u1ee5c<\/li>\n<\/ul>\n<p>Nh\u1eefng t\u00ednh n\u0103ng n\u00e0y \u0111\u1eb7c bi\u1ec7t c\u00f3 gi\u00e1 tr\u1ecb khi \u0111\u1ea7u t\u01b0 v\u00e0o c\u00e1c ng\u00e0nh bi\u1ebfn \u0111\u1ed9ng nh\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc, n\u01a1i vi\u1ec7c \u0111\u1ecbnh k\u00edch th\u01b0\u1edbc v\u1ecb th\u1ebf v\u00e0 qu\u1ea3n l\u00fd r\u1ee7i ro r\u1ea5t quan tr\u1ecdng.<\/p>\n<h2>\ud83e\uddec Intellia Therapeutics N\u0103m 2025: Ti\u00ean Phong Ch\u1ec9nh S\u1eeda Gen<\/h2>\n<p>Intellia l\u00e0 c\u00f4ng ty d\u1eabn \u0111\u1ea7u trong l\u0129nh v\u1ef1c li\u1ec7u ph\u00e1p d\u1ef1a tr\u00ean CRISPR, ph\u00e1t tri\u1ec3n c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb c\u00f3 th\u1ec3 c\u00e1ch m\u1ea1ng h\u00f3a c\u00e1ch ch\u00fang ta x\u1eed l\u00fd c\u00e1c b\u1ec7nh di truy\u1ec1n. C\u00f4ng ty t\u1eadp trung v\u00e0o c\u1ea3 ph\u01b0\u01a1ng ph\u00e1p in vivo (trong c\u01a1 th\u1ec3) v\u00e0 ex vivo (ngo\u00e0i c\u01a1 th\u1ec3) gi\u00fap h\u1ecd c\u00f3 v\u1ecb th\u1ebf \u0111\u1ed9c \u0111\u00e1o trong l\u0129nh v\u1ef1c ch\u1ec9nh s\u1eeda gen<a href=\"https:\/\/crisprmedicinenews.com\/company\/card\/intellia-therapeutics\/\">CRISPR Medicine News<\/a>.<\/p>\n<p>C\u00e1c ch\u01b0\u01a1ng tr\u00ecnh ti\u00ean ti\u1ebfn nh\u1ea5t c\u1ee7a h\u1ecd nh\u1eafm \u0111\u1ebfn ph\u00f9 m\u1ea1ch di truy\u1ec1n v\u00e0 amyloidosis transthyretin &#8211; c\u00e1c b\u1ec7nh \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u00e0ng ng\u00e0n b\u1ec7nh nh\u00e2n tr\u00ean to\u00e0n th\u1ebf gi\u1edbi v\u1edbi l\u1ef1a ch\u1ecdn \u0111i\u1ec1u tr\u1ecb h\u1ea1n ch\u1ebf. Vi\u1ec7c t\u00e1i c\u1ea5u tr\u00fac c\u00f4ng ty \u0111\u1ea7u n\u0103m 2025, d\u00f9 \u0111au \u0111\u1edbn v\u1edbi vi\u1ec7c gi\u1ea3m 27% nh\u00e2n s\u1ef1<a href=\"https:\/\/www.fiercebiotech.com\/biotech\/intellia-citing-challenging-market-environment-culls-27-staff-it-takes-ax-pipeline\">Fierce Biotech<\/a>, th\u1ef1c s\u1ef1 \u0111\u00e3 c\u1ee7ng c\u1ed1 s\u1ef1 t\u1eadp trung v\u00e0o c\u00e1c t\u00e0i s\u1ea3n giai \u0111o\u1ea1n cu\u1ed1i \u0111\u1ea7y h\u1ee9a h\u1eb9n n\u00e0y.<\/p>\n<p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb n\u0103m 2025<\/strong>: Tr\u1ee5 s\u1edf ch\u00ednh c\u1ee7a Intellia t\u1ea1i Cambridge c\u00f3 m\u1ed9t &#8220;B\u1ee9c t\u01b0\u1eddng Danh V\u1ecdng CRISPR&#8221; tr\u01b0ng b\u00e0y c\u00e1c chu\u1ed7i DNA \u0111\u01b0\u1ee3c ch\u1ec9nh s\u1eeda b\u1edfi c\u00f4ng ngh\u1ec7 c\u1ee7a h\u1ecd \u0111\u00e3 d\u1eabn \u0111\u1ebfn c\u00e1c \u0111\u1ed9t ph\u00e1 \u0111i\u1ec1u tr\u1ecb &#8211; m\u1ed9t l\u1eddi nh\u1eafc nh\u1edf li\u00ean t\u1ee5c cho nh\u00e2n vi\u00ean r\u1eb1ng h\u1ecd \u0111ang th\u1ef1c s\u1ef1 vi\u1ebft l\u1ea1i m\u00e3 gen \u0111\u1ec3 c\u1ee9u s\u1ed1ng con ng\u01b0\u1eddi.<\/p>\n"},"faq":[{"question":"Intellia Therapeutics l\u00e0 c\u00f4ng ty g\u00ec?","answer":"Intellia Therapeutics l\u00e0 c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u00ean phong trong l\u0129nh v\u1ef1c ch\u1ec9nh s\u1eeda gen s\u1eed d\u1ee5ng c\u00f4ng ngh\u1ec7 CRISPR \u0111\u1ec3 ph\u00e1t tri\u1ec3n c\u00e1c li\u1ec7u ph\u00e1p \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh di truy\u1ec1n."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu NTLA?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu NTLA th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n h\u1ed7 tr\u1ee3 NASDAQ, b\u1eb1ng c\u00e1ch t\u1ea1o t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 NTLA v\u00e0 \u0111\u1eb7t l\u1ec7nh mua theo h\u01b0\u1edbng d\u1eabn t\u1eebng b\u01b0\u1edbc."},{"question":"R\u1ee7i ro khi \u0111\u1ea7u t\u01b0 v\u00e0o Intellia Therapeutics l\u00e0 g\u00ec?","answer":"R\u1ee7i ro bao g\u1ed3m th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, r\u00e0o c\u1ea3n ph\u00e1p l\u00fd, chi ph\u00ed nghi\u00ean c\u1ee9u v\u00e0 ph\u00e1t tri\u1ec3n cao, t\u00e2m l\u00fd th\u1ecb tr\u01b0\u1eddng ti\u00eau c\u1ef1c v\u00e0 c\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty CRISPR kh\u00e1c."},{"question":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu NTLA trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu NTLA c\u00f3 th\u1ec3 t\u0103ng l\u00ean 16-18 USD v\u00e0o cu\u1ed1i n\u0103m 2025, 22-25 USD n\u0103m 2026, 35-45 USD n\u0103m 2028 v\u00e0 50-65 USD v\u00e0o n\u0103m 2030 d\u1ef1a tr\u00ean ti\u1ebfn tri\u1ec3n l\u00e2m s\u00e0ng v\u00e0 th\u01b0\u01a1ng m\u1ea1i h\u00f3a."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 v\u00e0o NTLA?","answer":"Pocket Option cung c\u1ea5p s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh, \u0111a d\u1ea1ng ph\u01b0\u01a1ng th\u1ee9c n\u1ea1p r\u00fat, kh\u1ea3 n\u0103ng mua c\u1ed5 phi\u1ebfu l\u1ebb v\u00e0 t\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c, gi\u00fap nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi d\u1ec5 d\u00e0ng ti\u1ebfp c\u1eadn c\u1ed5 phi\u1ebfu NTLA."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Intellia Therapeutics l\u00e0 c\u00f4ng ty g\u00ec?","answer":"Intellia Therapeutics l\u00e0 c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u00ean phong trong l\u0129nh v\u1ef1c ch\u1ec9nh s\u1eeda gen s\u1eed d\u1ee5ng c\u00f4ng ngh\u1ec7 CRISPR \u0111\u1ec3 ph\u00e1t tri\u1ec3n c\u00e1c li\u1ec7u ph\u00e1p \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh di truy\u1ec1n."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu NTLA?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu NTLA th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n h\u1ed7 tr\u1ee3 NASDAQ, b\u1eb1ng c\u00e1ch t\u1ea1o t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 NTLA v\u00e0 \u0111\u1eb7t l\u1ec7nh mua theo h\u01b0\u1edbng d\u1eabn t\u1eebng b\u01b0\u1edbc."},{"question":"R\u1ee7i ro khi \u0111\u1ea7u t\u01b0 v\u00e0o Intellia Therapeutics l\u00e0 g\u00ec?","answer":"R\u1ee7i ro bao g\u1ed3m th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, r\u00e0o c\u1ea3n ph\u00e1p l\u00fd, chi ph\u00ed nghi\u00ean c\u1ee9u v\u00e0 ph\u00e1t tri\u1ec3n cao, t\u00e2m l\u00fd th\u1ecb tr\u01b0\u1eddng ti\u00eau c\u1ef1c v\u00e0 c\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty CRISPR kh\u00e1c."},{"question":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu NTLA trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu NTLA c\u00f3 th\u1ec3 t\u0103ng l\u00ean 16-18 USD v\u00e0o cu\u1ed1i n\u0103m 2025, 22-25 USD n\u0103m 2026, 35-45 USD n\u0103m 2028 v\u00e0 50-65 USD v\u00e0o n\u0103m 2030 d\u1ef1a tr\u00ean ti\u1ebfn tri\u1ec3n l\u00e2m s\u00e0ng v\u00e0 th\u01b0\u01a1ng m\u1ea1i h\u00f3a."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 v\u00e0o NTLA?","answer":"Pocket Option cung c\u1ea5p s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh, \u0111a d\u1ea1ng ph\u01b0\u01a1ng th\u1ee9c n\u1ea1p r\u00fat, kh\u1ea3 n\u0103ng mua c\u1ed5 phi\u1ebfu l\u1ebb v\u00e0 t\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c, gi\u00fap nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi d\u1ec5 d\u00e0ng ti\u1ebfp c\u1eadn c\u1ed5 phi\u1ebfu NTLA."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T10:19:58+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA)\",\"datePublished\":\"2025-08-20T10:19:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"datePublished\":\"2025-08-20T10:19:58+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T10:19:58+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA)","datePublished":"2025-08-20T10:19:58+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","datePublished":"2025-08-20T10:19:58+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Intellia Therapeutics, Inc. (NTLA)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":340097,"slug":"how-to-buy-intellia-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Intellia Therapeutics, Inc. (NTLA) - Investimento em a\u00e7\u00f5es da Intellia Therapeutics, Inc. (NTLA)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-intellia-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/340098","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=340098"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/340098\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334072"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=340098"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=340098"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=340098"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}